Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net (loss) income attributable to Agrify Corporation	$ (10,327)	$ 1,780
Adjustments to reconcile net loss attributable to Agrify Corporation to net cash used in operating activities:
Depreciation and amortization	445	1,052
Amortization of premium on investment securities		224
Amortization of debt discount	147	223
Interest on investment securities		(248)
Amortization of issuance costs	24	143
Deferred income taxes		(200)
Stock based compensation expense	859	953
Non-cash interest income		(406)
Change in fair value of warrant liabilities	(2,672)	(10,785)
Loss on extinguishment of notes payable, net	4,620
Early termination of lease		26
Income attributable to non-controlling interests		1
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(127)	(838)
Inventory	1,401	(16,361)
Prepaid expenses and other current assets	(31)	(890)
Right of use assets, net	(133)	(20)
Other non-current assets	173
Accounts payable	585	(2,838)
Accrued expenses and other current liabilities	(3,744)	(2,120)
Operating lease liabilities	184
Deferred revenue	(873)	(571)
Net cash used in operating activities	(9,469)	(30,875)
Cash flows from investing activities:
Purchases of property and equipment	(59)	(3,728)
Purchase of securities		(76,097)
Proceeds from sale of securities	10,446	82,460
Issuance of loan	(592)	(12,487)
Cash paid for business combination, net of cash acquired		(3,513)
Net cash provided by (used in) investing activities	9,795	(13,365)
Cash flows from financing activities:
Proceeds from issuance of debt and warrants in private placement		62,405
Proceeds from issuance of Common Stock and warrants in private placement, net of fees		25,797
Proceeds from “at the market” Program, net	1,478
Proceeds from Employee Stock Option Plan shares	25
Proceeds from exercise of options		10
Proceeds from exercise of warrants		1
Repayment of notes payable, other	(71)
Repayment of debt in private placement	(10,307)
Payments on insurance financing loan	(396)	(428)
Payments on other financing loans	(1)	(273)
Payments of financing leases	(35)	(81)
Net cash (used in) provided by financing activities	(9,307)	87,431
Net (decreased) increase in cash, cash equivalents, and restricted cash	(8,981)	43,191
Cash, cash equivalents, and restricted cash at the beginning of period	10,457	12,014
Cash, cash equivalents, and restricted cash at the end of period	1,476	55,205
Cash, cash equivalents, and restricted cash at end of period
Cash and cash equivalents	1,476	25,205
Restricted cash		30,000
Total cash, cash equivalents, and restricted cash at the end of period	1,476	55,205
Supplemental disclosures of non-cash flow information
Initial fair value of warrants		40,496
Financing of prepaid insurance	$ 1,820	$ 1,928